BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 21459041)

  • 21. [Nrf2 as a chemoprevention target in gastrointestinal carcinoma].
    Gao P; Tang XW; Wang XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):453-63. PubMed ID: 22927084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs.
    Singh A; Ling G; Suhasini AN; Zhang P; Yamamoto M; Navas-Acien A; Cosgrove G; Tuder RM; Kensler TW; Watson WH; Biswal S
    Free Radic Biol Med; 2009 Feb; 46(3):376-86. PubMed ID: 19027064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of PM2.5 on the level of nuclear factor erythroid-2 related factor 2 in chronic obstructive pulmonary disease mice and its relationship with oxidative stress].
    Zhao QJ; Liu XJ; Zeng XL; Bao HR
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2241-5. PubMed ID: 27480657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress.
    Tan KP; Yang M; Ito S
    Mol Pharmacol; 2007 Nov; 72(5):1380-90. PubMed ID: 17724089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.
    Singh S; Vrishni S; Singh BK; Rahman I; Kakkar P
    Free Radic Res; 2010 Nov; 44(11):1267-88. PubMed ID: 20815789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.
    Sidhaye VK; Holbrook JT; Burke A; Sudini KR; Sethi S; Criner GJ; Fahey JW; Berenson CS; Jacobs MR; Thimmulappa R; Wise RA; Biswal S
    Respir Res; 2019 Aug; 20(1):190. PubMed ID: 31429757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular response to cigarette smoke and oxidants: adapting to survive.
    Cantin AM
    Proc Am Thorac Soc; 2010 Nov; 7(6):368-75. PubMed ID: 21030515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat stress activates interleukin-8 and the antioxidant system via Nrf2 pathways in human dental pulp cells.
    Chang SW; Lee SI; Bae WJ; Min KS; Shin ES; Oh GS; Pae HO; Kim EC
    J Endod; 2009 Sep; 35(9):1222-8. PubMed ID: 19720220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.
    Rangasamy T; Cho CY; Thimmulappa RK; Zhen L; Srisuma SS; Kensler TW; Yamamoto M; Petrache I; Tuder RM; Biswal S
    J Clin Invest; 2004 Nov; 114(9):1248-59. PubMed ID: 15520857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.
    Harvey CJ; Thimmulappa RK; Sethi S; Kong X; Yarmus L; Brown RH; Feller-Kopman D; Wise R; Biswal S
    Sci Transl Med; 2011 Apr; 3(78):78ra32. PubMed ID: 21490276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoplasmic reticulum stress and related apoptosis in the lungs of a chronic obstructive pulmonary disease rat model].
    He BM; Luo BL; Peng ZY; Yuan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 May; 34(5):375-9. PubMed ID: 21729629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances in the study of Nrf2 and inflammatory respiratory diseases].
    Xie JL; Lin MB; Hou Q
    Yao Xue Xue Bao; 2015 Sep; 50(9):1080-7. PubMed ID: 26757542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress.
    Fratta Pasini AM; Ferrari M; Stranieri C; Vallerio P; Mozzini C; Garbin U; Zambon G; Cominacini L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1733-43. PubMed ID: 27555763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review.
    Comandini A; Marzano V; Curradi G; Federici G; Urbani A; Saltini C
    Pulm Pharmacol Ther; 2010 Dec; 23(6):482-92. PubMed ID: 20594977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema.
    Goven D; Boutten A; Leçon-Malas V; Marchal-Sommé J; Amara N; Crestani B; Fournier M; Lesèche G; Soler P; Boczkowski J; Bonay M
    Thorax; 2008 Oct; 63(10):916-24. PubMed ID: 18559366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease.
    Sun X; Chen L; He Z
    Curr Drug Metab; 2019; 20(4):301-304. PubMed ID: 30827233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.